celecoxib and brefeldin a

celecoxib has been researched along with brefeldin a in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Chang, X; Cui, PF; He, YJ; Jiang, HL; Jin, QR; Qiao, JB; Xiao, Y; Xing, L; Yu, RY; Zhou, TJ	1

Other Studies

2 other study(ies) available for celecoxib and brefeldin a

Article	Year
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis. Biomaterials science, 2018, Jul-24, Volume: 6, Issue:8 Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Breast Neoplasms; Brefeldin A; Celecoxib; Cell Movement; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Golgi Apparatus; HeLa Cells; Humans; Mice; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglactin 910; Tumor Cells, Cultured	2018

Article

Year

Identifying off-target effects and hidden phenotypes of drugs in human cells.

Nature chemical biology, 2006, Volume: 2, Issue:6

Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006

Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis.

Biomaterials science, 2018, Jul-24, Volume: 6, Issue:8

Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Breast Neoplasms; Brefeldin A; Celecoxib; Cell Movement; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Golgi Apparatus; HeLa Cells; Humans; Mice; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglactin 910; Tumor Cells, Cultured

2018